Immunovant Inc. Common Stock vs Permian Resources Corporation Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Permian Resources Corporation Class A Common Stock trades at $22.64 (market cap $18.57B). The key difference: Permian Resources Corporation Class A Common Stock is far larger — about 2.8× Immunovant Inc. Common Stock's market cap, and Permian Resources Corporation Class A Common Stock pays a 2.84% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Permian Resources Corporation Class A Common Stock for 0 Days on average.
| IMVT | PR | |
|---|---|---|
Market Cap | $6.62B | $18.57B |
Volume | 1,131,364 | 7,560,985 |
Sector | Health | Energy |
52-Week High | $44.96 | $24.49 |
52-Week Low | $17.03 | $12.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $21.57B |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Permian Resources explores for and produces oil and natural gas in the Permian Basin. Its operations are concentrated in the Delaware Basin of West Texas and New Mexico.
Read more on PR →